Refine by
Infused Digital Upgrade System Articles & Analysis
18 news found
Flowonix Medical Inc. of New Jersey, and Colorado-based Cerebral Therapeutics, announced today the first patients implanted with the Prometra II Programmable Infusion System in the Australian Direct Drug Administration for Refractory Epilepsy (ADDRESS) clinical trial at St. Vincent's Hospital, Melbourne, Australia. The jointly developed therapy features a micro-infusion device that tightly ...
Fresenius Kabi has been selected to exhibit the Ivenix Infusion System at the Vizient Innovative Technology Exchange. Vizient, Inc, the nation’s largest member-driven health care performance improvement company, will hold the Exchange on October 17, 2022, in Dallas. The annual Innovative Technology Exchange offers selected suppliers the opportunity to demonstrate their technologies to ...
Following the announced closing of the acquisition of Ivenix and its advanced infusion pump technology, Fresenius Kabi now offers healthcare professionals a broad and expanding portfolio of advanced infusion pumps and solutions to meet health care needs across the continuum of care. Fresenius Kabi is the leading provider of IV pumps and solutions in Europe. The company is now investing to ...
Deborah Heart and Lung Center announces its successful hospital-wide go live with Ivenix, a modern smart infusion pump system. “Though everyone is familiar with IV pump delivery systems used to administer medications during a patient’s hospital stay, improvements in technology have allowed us to do it in a controlled and measured way,” said Rita Zenna, RN, Deborah’s Vice ...
BioQ Pharma Incorporated (“the Company”), a specialty pharmaceutical company, today announced receipt of CE mark approval in the European Union for its OneDose ReadyfusOR Gen2, single-use medication dispenser. The OneDose ReadyfusOR Gen2 is the second generation of the Company’s original OneDose ReadyfusOR infusion system and was developed to further improve patient convenience. ...
Ivenix, Inc., a medical technology company with the vision of eliminating infusion-related patient harm, today announced its medical director, Matthew B. Weinger, M.D., M.S., will deliver the 2020 Ellison C. Pierce Memorial Safety Lecture at ANESTHESIOLOGY® 2020, the annual meeting of the American Society of Anesthesiologists (ASA), on Saturday, Oct. 3. Dr. Weinger’s presentation on ...
Flowonix Medical, Inc. today announced United States Food and Drug Administration (FDA) approval to market the Prometra II Programmable Pump System for use with intrathecal baclofen. Flowonix introduced the Prometra II 40mL pump to the US market in November 2019, providing patients and clinicians a choice between 20 mL and 40 mL capacities when choosing an intrathecal pump delivery device. The ...
BioQ Pharma Incorporated (“the Company”), a specialty pharmaceutical company, today announced that Dr. Marijn Dekkers has agreed to join the Company’s board of directors. Dr. Dekkers is founder and chairman of Novalis LifeSciences, an investment and advisory firm for the life science industry. He served as CEO of Bayer AG, a global life sciences company, from 2010 to 2016 and ...
BioQ Pharma Incorporated, a specialty pharmaceutical company, today announced that it has entered into a Development, Supply, Distribution Agreement with Avanos Medical, Inc. (NYSE: AVNS, “Avanos”). Under the agreement, the parties will work together to obtain appropriate regulatory approvals and commercialize self-contained, infusible, non-opioid post-operative pain pharmaceutical ...
BioQ Pharma Incorporated (“the Company”), a specialty pharmaceutical company, today announced that the Australian Therapeutic Goods Administration (TGA) has approved the Company’s Propofusor product containing 1% propofol in a single-use dispensing system. Uses of the Propofusor include the induction and maintenance of general anesthesia, sedation of mechanically ventilated ...
Flowonix Medical, Inc. today announced United States Food and Drug Administration (FDA) approval to market the Flowonix Maestro™ Software for Clinician Programmers used to program Prometra® Pump Systems. The new software is designed to improve the user experience for both clinicians and patients. Flowonix expects to begin introducing the new software to customers and implementing the ...
BioQ Pharma Incorporated (“the Company”), a specialty pharmaceutical company focused on developing and commercializing ready-to-use infusible pharmaceuticals, today announced the positive closure of a European regulatory procedure for its propofol product. The Company’s ready-to-use infusion pharmaceutical includes the propofol drug product and delivery system in a single-use ...
BioQ Pharma Incorporated, a specialty pharmaceutical company, announced today that the Company will be presenting at the 38th Annual Canaccord Genuity Growth Conference to be held in Boston Massachusetts on August 8th and 9th, 2018. Josh Kriesel, President and Chief Executive Officer, is scheduled to present on Wednesday, August 8th at 12:30 p.m. Eastern Daylight Time. About BioQ Pharma BioQ ...
BioQ Pharma Incorporated (“the Company”), a specialty pharmaceutical company, today announced that Dr. Marijn Dekkers has become a strategic advisor to the Company. Concurrent, with his advisory role, Dr. Dekkers also made an investment in BioQ Pharma through his advisory and investment vehicle Novalis LifeScience LLC. Dr. Dekkers is currently the Chairman of Unilever and the Founder ...
Flowonix Medical announced today the launch of the Flowonix Maestro ProView platform, an enhanced, Windows®-based platform that improves records management with the Prometra® Clinician Programmer. The new software platform displays information in a user-friendly interface that enables simplified filtering by patient name and date, while also presenting the programming history details in ...
Flowonix Medical, Inc. and Cerebral Therapeutics, Inc. announced today the successful implant of the fifth patient in the ADDRESS (Australian Direct Drug Administration for Refractory Epilepsy) trial. The jointly developed therapy features a micro-infusion device which tightly controls drug delivery to a region of the brain for patients with medically refractory epilepsy. "The study ...
Fortrans Inc. announces new patent pending technology to mix gases into water and other media. The Dif-JET System is non-fouling and does not depend on bubble technology to mix gases into water. DiF-JET single and combination Gas Infusion Systems are highly efficient at mixing beneficial gases such as oxygen, carbon dioxide, nitrogen and air into water or other media. DiF-JET inline non-fouling ...
Gas inFusion technologies developed by inVentures include passive and active systems for transferring dissolved gasses to groundwater, surface water, and wastewater. The iSOC/HiSOC systems are employed in passive treatment wells for delivering oxygen, hydrogen, and cometabolic gas substrates to aid in bioremediation. In comparison, inFusion gPRO systems are used for the same applications, but ...